Abstract: The invention provides humanized anti-human Tau(pS422) antibodies and methods of using the same.
Type:
Grant
Filed:
September 17, 2020
Date of Patent:
February 7, 2023
Assignee:
Hoffman-La Rocher Inc.
Inventors:
Stefan Dengl, Thomas Emrich, Guy Georges, Ulrich Goepfert, Fiona Grueninger, Adrian Hugenmatter, Anton Jochner, Hubert Kettenberger, Joerg Moelleken, Ekkehard Moessner, Olaf Mundigl, Jens Niewoehner, Tilman Schlothauer, Michael Molhoj, Kevin Brady